Fig. 4.
a) EEF1A2 expression in the TCGA cohort (n = 499; dashed line indicated an expression z-score of 2). b) Tumors with an elevated EEF1A2 expression had a significantly shorter BCR-free survival
a) EEF1A2 expression in the TCGA cohort (n = 499; dashed line indicated an expression z-score of 2). b) Tumors with an elevated EEF1A2 expression had a significantly shorter BCR-free survival